Sponsored • Connecting Precision Medicine with Smart Healthcare
Taipei Brings Six Biomedical Innovations to MEDICA 2026
Six Taipei-based biomedical companies will showcase innovations in precision medicine and smart healthcare at MEDICA 2026 (Nov. 16–19, Düsseldorf). Supported by the Taipei City Government, the Taipei Pavilion will connect local innovators with international partners and global market opportunities.
Image source: BioSenseTek
Smart Hospital Care: Real-Time Patient Monitoring
BioSenseTek specializes in electrophysiology integration and wireless vital-sign monitoring. Its Wearable Telemetry IoT System monitors heart rate, respiration rate, skin temperature, ECG, and patient location tracking with 3rd party vital data into a central monitoring platform. Designed for smart wards, nursing stations, and emergency care, the wearable monitor weighs about 32 grams and provides over seven days of battery life.
>> Visit BioSenseTek at MEDICA 2026: Hall 16, C23-6
Company website: https://biosensetek.com/solution.php
Advanced Medical Technology for Everyday Care
Image source: JUBILEE
JUBILEE Biomedical leverages proprietary cold plasma, ultrasound, and microbubble technologies to develop innovative solutions for medical aesthetics, skin health and care, and chronic wound care. At MEDICA, JUBILEE will showcase JUBI Plasma, bringing professional medical technologies into daily and at-home skin care, while expanding its applications across dermatological care, long-term care, and wound management.
>> Visit JUBILEE International Biomedical at MEDICA 2026: Hall 16, C23-2
Company website: https://en.jubileebiomed.com/
Precision Oncology: From Genomic Data to Treatment Decisions
Image source: ACT Genomics
ACT Genomics is advancing precision oncology by transforming complex genomic data into actionable insights that support more informed cancer care. Through next-generation sequencing (NGS), advanced bioinformatics, and a proprietary genomic database, ACT Genomics provides comprehensive genomic profiling solutions designed to support treatment selection, disease monitoring, and Biopharma programs.
Backed by a CAP-accredited laboratory, ACT Genomics combines robust laboratory capabilities with genomic interpretation to help bridge the gap between molecular profiling and clinical decision-making.
>> Visit ACT Genomics at MEDICA 2026: Hall 16, C23-7
Company website: https://www.actgenomics.com/?r=0
Faster Diagnostics: AST Results in as Little as Four Hours
Origin Biotechnology develops rapid molecular diagnostics for SMA, DMD, Fragile X syndrome, and thalassemia. At MEDICA, it will showcase the E-AST COMBO SYSTEM, which uses microfluidic impedance technology to perform antimicrobial susceptibility testing directly from positive blood cultures. The automated platform reduces the conventional 36–48-hour process to as little as four hours, enabling faster clinical decision-making.
>> Visit Origin Biotechnology at MEDICA 2026: Hall 16, C23-4
Company website: https://www.oribio.com.tw/en/home
Image source: Origin Biotechnologies
Connected Mobile Healthcare: Wearables RPM, HaH, Digital Health Platform
Founded in 2008, GuiderCare integrates medical wearable IoT systems, remote monitoring, and AI-enabled digital health B2B platforms. Its 300C and 900Q devices use Bluetooth, 4G LTE, and GPS to collect heart rate, BP, SpO₂, body temperature, respiration rate, HRV, sleep, fatigue, and activity data. The solution supports remote monitoring and health management across hospitals, nursing homes, and homecare settings.
It also offers a professional mobile health management app and a personal AI assistant, which are very useful for home care and hospital at home.
>> Visit GuiderCare at MEDICA 2026: Hall 16, C23-3
Company website: https://www.guidercare.com/
Image source: GuiderCare
Privacy-Preserving AI for Smarter Healthcare
DeCloak Intelligences combines privacy protection with AI innovation. Its AipA Smart Healthcare System uses proprietary differential privacy and de-identification algorithms to irreversibly protect identifiable clinical imagery while preserving its value for AI analysis. Even on de-identified footage, the system can detect falls, lying in bed, sitting at the bedside, and unplanned tube removal. The technology is designed in alignment with GDPR, HIPAA, and NIST SP 800-226.
>> Visit DeCloak Intelligences at MEDICA 2026: Hall 16, C23-5
Company website: https://de-cloak.com/en/home-en/
Image source: DeCloak Intelligences
At MEDICA 2026, the six companies will showcase Taipei’s capabilities across patient monitoring, advanced medical technologies, precision oncology, rapid diagnostics, digital health, and privacy-preserving AI, while pursuing international partnerships and new market opportunities.
Source: Department of Economic Development, Taipei City Government
22.10.2026
